By Najiyya Budaly ( February 20, 2026, 2:02 PM GMT) -- Big pharmaceutical companies circling mature drug candidates as they seek to fill a revenue hole of more than $200 billion — created by a looming patent cliff — might provide respite to venture capital investors that have struggled to exit biotech companies since COVID-19, experts say....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.